Skip to search boxSkip to navigationSkip to main content

A conformational and structure-activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues

  • J. R. Dimmock(corresponding author)
    ,
  • M. P. Padmanilayam
    ,
  • R. N. Puthucode
    ,
  • A. J. Nazarali
    ,
  • N. L. Motaganahalli
    ,
  • G. A. Zello
*Corresponding author for this work
  • University of Saskatchewan
    ,
  • University of Alberta
    ,
  • KU Leuven
    ,
  • Wayne State University
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

A series of 3,5-bis(arylidene)-4-piperidones 1 and related N-acryloyl analogues 2 were prepared as candidate cytotoxic agents with a view to discerning those structural features which contributed to bioactivity. A number of the compounds were markedly cytotoxic toward murine P388 and L1210 leukemic cells and also to human Molt 4/C8 and CEM neoplasms. Approximately 40% of the IC50 values generated were lower than the figures obtained for melphalan. In virtually all cases, the N-acyl compounds were significantly more bioactive than the analogues 1. In general, structure - activity relationships revealed that the cytotoxicity of series 1 was correlated positively with the size of the aryl substituents, while in series 2, a -σ relationship was established. In particular, various angles and interatomic distances were obtained by molecular modeling, and the presence of an acryloyl group on the piperidyl nitrogen atom in series 2 affected the relative locations of the two aryl rings. This observation, along with some differences in distances between various atoms in series 1 and 2, may have contributed to the disparity in cytotoxicity between 1 and 2. The results obtained by X-ray crystallography of representative compounds were mainly in accordance with the observations noted by molecular modeling. Selected compounds interfered with the biosynthesis of DNA, RNA, and protein in murine L1210 cells, while others were shown to cause apoptosis in the human Jurkat leukemic cell line. This study has revealed the potential of these molecules for development as cytotoxic and anticancer agents.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 586-593 (8 pages)

Journal (Volume, Issue Number)

Journal of Medicinal Chemistry (Volume 44, Issue 4)

Publication milestones

  • Published - 02/15/2001

Publication status

Published - 02/15/2001

ISSN

0022-2623

Publication IDs

  • Scopus: 0035865786
  • PubMed: 11170648

Publication metrics

Metrics

Scopus
citations
SciVal
citations
190
SciVal
FWCI
2.02
SciVal
Author count
15
SciVal
Paper percentile
97
SciVal
Top percentile
5
Fractional count
1
Fractional count
0.07
Fractional count
14
Fractional count
0.93
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
215
Captures
42